HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Retinitis Pigmentosa 25

mutation in EYS

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Eye Diseases: 3522
- Retinal Diseases: 3014
  - Retinal Degeneration: 4078
    - Retinal Dystrophies: 743
      - Retinitis Pigmentosa: 3975
        Retinitis Pigmentosa 25: 1
- Hereditary Eye Diseases: 18
  - Retinitis Pigmentosa: 3975
    - Retinitis Pigmentosa 25: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Hereditary Eye Diseases: 18
    - Retinitis Pigmentosa: 3975
      - Retinitis Pigmentosa 25: 1

Experts

1.	Amack, Jeffrey D: 1 article (11/2016)
2.	Cao, Shuqin: 1 article (11/2016)
3.	Hu, Huaiyu: 1 article (11/2016)
4.	Li, Jing: 1 article (11/2016)
5.	Liu, Yu: 1 article (11/2016)
6.	Natale, Brianna N: 1 article (11/2016)
7.	Wang, Dongliang: 1 article (11/2016)
8.	Yu, Miao: 1 article (11/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Retinitis Pigmentosa 25:

1.	Extracellular Matrix ProteinsIBA 11/15/2016 - "Mutations in the extracellular matrix protein eyes shut homolog (EYS) cause photoreceptor degeneration in patients with retinitis pigmentosa 25 (RP25). "